Extract

This is a double-blind, randomised, placebo-controlled, two-part adaptive clinical trial. The trial is designed to investigate the efficacy and safety of multiple dosing regimens of selepressin and to confirm the efficacy and safety of one dosing regimen in treatment of adult patients with septic shock requiring vasopressor.

Inclusion criteria

• Septic shock

Country

• Belgium
• Denmark
• France
• Netherlands
• United States

Links

• ictrp
• nct